SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950134-06-002598
Filing Date
2006-02-13
Accepted
2006-02-13 12:21:06
Documents
1
Group Members
MPM ASSET MANAGEMENT II LLCMPM ASSET MANAGEMENT II, L.P.MPM ASSET MANAGEMENT INVESTORS 2000B LLCMPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KGMPM BIOVENTURES II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f17269sc13d.htm SC 13D 158735
  Complete submission text file 0000950134-06-002598.txt   160737
Mailing Address
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
METABASIS THERAPEUTICS INC (Subject) CIK: 0001053221 (see all company filings)

IRS No.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-80372 | Film No.: 06601827
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 6174259200
MPM BIOVENTURES II QP LP (Filed by) CIK: 0001264830 (see all company filings)

IRS No.: 043523699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D